Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients  by Li, Jin et al.
International Journal of Infectious Diseases 42 (2016) 34–39Age and Ebola viral load correlate with mortality and survival time
in 288 Ebola virus disease patients
Jin Li a,1, Hui-Juan Duan a,1, Hao-Yang Chen a,1, Ying-Jie Ji a, Xin Zhang a, Yi-Hui Rong a,
Zhe Xu a, Li-Jian Sun a, Ji-Yuan Zhang a, Li-Ming Liu a, Bo Jin a, Jian Zhang a, Ning Du a,
Hai-Bin Su a, Guang-Ju Teng a, Yue Yuan a, En-Qiang Qin a, Hong-Jun Jia a, Shu Wang a,
Tong-Sheng Guo a, Ye Wang a, Jin-Song Mua, Tao Yan a, Zhi-Wei Li a, Zheng Dong a,
Wei-Min Nie a, Tian-Jun Jiang a, Chen Li a, Xu-Dong Gao a, Dong Ji a, Ying-Jie Zhuang a,
Lei Li a, Li-Fu Wang a, Wen-Gang Li a, Xue-Zhang Duan a, Yin-Ying Lu a, Zhi-Qiang Sun a,
Alex B.J. Kanu b, Sheku M. Koroma b, Min Zhao a,*, Jun-Sheng Ji a, Fu-Sheng Wang a,**
a Beijing 302 Hospital, Beijing, 100039, China
b Jui Government Hospital (Sierra Leone –China Friendship Hospital), Kossoh Town, Western Area Rural District, Sierra Leone
A R T I C L E I N F O
Article history:
Received 22 June 2015
Received in revised form 22 October 2015
Accepted 24 October 2015






S U M M A R Y
Background: A Chinese medical team managed Ebola virus disease (EVD) patients in Sierra Leone from
October 2014 to March 2015 and attended to 693 suspected patients, of whom 288 had conﬁrmed
disease.
Methods: A retrospective study was conducted of the 288 patients with conﬁrmed disease. Clinical
symptoms, manifestations, and serum viral load were analyzed and compared among the different
groups for mortality and survival time.
Results: Among the 288 conﬁrmed EVD patients (149 male and 139 female, median age 28 years, and
median log viral load 6.68), 98 died, 36 recovered, and 154 were lost to follow-up. Common symptoms
were fever (77.78%), fatigue (64.93%), abdominal pain (64.58%), headache (62.85%), and diarrhea
(61.81%). Compared to patients aged < 18 years, those who were older than 40 years had a higher
probability of death (odds ratio 2.855, p = 0.044). Patients with a viral load of >106 copies/ml had a
higher case fatality rate than those with <106 copies/ml (odds ratio 3.095, p = 0.004). Cox regression
showed that age, viral load, and the presence of diarrhea correlated with mortality.
Conclusion: Patients with a high viral load, of older age, and with diarrhea had a higher mortality and
shorter survival time.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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The ﬁrst outbreak of Ebola virus was described in 1976 near the
Ebola River in Zaire. The Ebola virus infected 318 cases and caused
280 deaths.1 Fever and bleeding were the major symptoms
observed at that time; therefore, the Ebola virus disease (EVD) was
initially termed Ebola hemorrhagic fever. To date, there have been* Corresponding author. Tel.: +86-10-66933402; fax: +86-10-66933402.
** Corresponding author. Tel.: +86 10 63879735; fax: +86 10 63879735.
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1 Jin Li, Hui-Juan Duan, and Hao-Yang Chen contributed equally to this work.
http://dx.doi.org/10.1016/j.ijid.2015.10.021
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).33 sporadic outbreaks worldwide, including 23 human-to-human
transmission epidemics, three laboratory-induced outbreaks, and
seven animal-to-human transmission outbreaks.2 The Ebola virus
is spread easily by close personal contact and by the use of
contaminated needles and syringes in hospitals and clinics.2,3 The
current epidemic began in Guinea in December 20134 and spread
rapidly to surrounding countries in West Africa (Sierra Leone and
Liberia). On August 8, 2014, the World Health Organization (WHO)
declared the epidemic to be a public health emergency of
international concern (PHEIC).5 By March 25, 2015, 24 907 proba-
ble and 10 326 conﬁrmed cases had been reported in West Africa.
Sierra Leone was the most affected country, with 11 841 conﬁrmed
cases and 3747 deaths.6ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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Sierra Leone had nearly collapsed because of a 10-year civil war. In
2014, the United Nations Development Program declared the
Human Development Index in Sierra Leone to be 0.374, ranking it
183rd in the world, and gave life expectancy as around 45.6 years.7
During the outbreak, Ebola infection spread rapidly in Sierra Leone,
particularly in the capital, Freetown. By March 25, 2015, there were
3382 conﬁrmed cases of EVD in Freetown, comprising 39.65% of
cases in the whole country.8 In response to the EVD outbreak, the
Sierra Leone government established an emergency response
system via the Ministry of Health and Sanitation (MoHS) and the
National Ebola Response Centre (NERC). The latter is responsible
for the coordination and management of medical treatment for
EVD patients among 29 Ebola treatment centers (ETCs), Ebola
holding centers (EHCs), and Community Care Centers (CCCs); these
have been run by medical teams from the USA, UK, France,
Australia, South Korea, China, and Cuba.9 The Sierra Leone – China
Friendship Hospital (Jui Government Hospital), built by the
Chinese government, is a well-equipped hospital in Freetown,
Sierra Leone. A Chinese medical team comprising 123 medical staff
started working in this hospital on September 15, 2014.
From October 1, 2014 to December 30, 2014, the Jui
Government Hospital was an EHC, and from December 31,
2014 to March 20, 2015, it was an ETC. Six hundred and ninety-
three probable cases and 288 conﬁrmed patients with EVD were
admitted to the Jui Government Hospital. The demographic
characteristics, signs and symptoms, and clinical outcomes of
these patients are reported here. Factors that inﬂuenced the
prognosis of these 288 EVD patients were analyzed. However,
the outcome is known for only 134 patients. Among those with
a known outcome, the case fatality rate was 73% and mortality
was associated with diarrhea, fatigue, and difﬁculty in swallowing.
These data validate previous studies and contribute to the




A patient who presented with fever, nausea, vomiting, diarrhea,
and bleeding was deﬁned as a ‘person under investigation’ (PUI).
The healthcare facilities that they visited had to report the case to
the NERC. Patients or their relatives could also call 117 (free
medical aid hotline in Sierra Leone). NERC would send an
ambulance to bring the patient to an EHC or alternatively let
the patient ‘walk in’ to an EHC.
In the triage area of the Jui Government Hospital, healthcare
workers (mostly nurses) collected the medical history of the PUI
and made their initial diagnosis. In accordance with the standard
routines, suspected EVD patients and probable EVD patients were
hospitalized and a blood sample collected. The blood sample was
sent to the mobile biological safety protection level 3 laboratory
(BSL-3) of the Chinese Center for Disease Control and Prevention
(China CDC). During observation, patients with severe dehydration
were given a venous infusion, and those with fever were given
antimalarial and antibiotic therapy. All medical practices were
performed in accordance with the WHO guidelines,10,11 and all
healthcare workers (including cleaners and security) were trained
and strictly examined on the processes for putting on and
removing personal protective equipment (PPE), treating contami-
nated waste safely, and the management of percutaneous or
mucocutaneous exposure. Patients with disease conﬁrmed by
reverse-transcription PCR (RT-PCR) were transferred to ETCs
coordinated by the NERC. Patients with a negative result by RT-
PCR (tested on blood samples collected three or more days after theonset of symptoms) were deﬁned as non-EVD patients and
discharged.
On December 31, 2014, the Jui Government Hospital was
formally made an ETC by authorization of the MoHS. Thereafter,
conﬁrmed patients were transferred to the ‘conﬁrmed ward’
(also in Jui, but isolated from the ‘suspect ward’) and received
comprehensive treatment. If the retest RT-PCR result was
negative and the patient’s condition had improved according to
the discharge standard, they were discharged.
2.2. Data collection
After admission, suspected and conﬁrmed patients underwent a
physical examination, their medical history details were collected
(including demographics, epidemiology, symptoms, signs, and
past history), and their general condition was evaluated; an ‘Ebola
case investigation form’ or a ‘Viral hemorrhagic fever case
investigation form’ (NERC) was completed. After daily ward
rounds, doctors would ﬁll in the EVD ‘patient observation sheet’.
All of these sheets were transmitted from the contaminated area
to the hygienic areas by closed circuit television (CCTV) or using a
Wi-Fi camera. The data were imported into an Excel database by
two staff, separately, to ensure accuracy.
The information technician contacted the patients transferred
to others ETCs or their relatives by telephone during follow-up, or
would ask for information from other ETCs. Usually, the informa-
tion comprised only the outcome (died or recovered) and the date
of the outcome.
2.3. Viral load test
After the registration of information, blood samples were
inactivated in a water bath at 60 8C for 1 h in the BSL-3 area. A
MagMAXTM-96 Viral RNA Isolation Kit (Applied Biosystems, Foster
City, CA, USA) was used to extract nucleic acid using a MagMAX
express 96 nucleic acid extraction instrument. After surface
disinfection, 50 ml of the sample was sent to the BSL-2 area for
the RT-PCR test. A standard curve was used to convert the value
of cycle times to the number of genome copies.
2.4. Supportive treatment for EVD patients
High fever and diarrhea usually lead to severe dehydration and
are the major reasons why EVD patients die. Thus, maintaining the
water and electrolyte balance in these patients is important. The
degree of dehydration in EVD patients is often evaluated on the
basis of state of consciousness, pulse, temperature, peripheral
blood capillary ﬁlling, skin elasticity, and daily urine output. In
general, all of the EVD patients received oral rehydration salts.
Simultaneously, some of the patients with severe dehydration
received intravenous ﬂuids if their condition permitted, which
mainly included sodium lactate Ringer’s solution and glucose
Ringer’s solution (GNS).
In addition, to prevent severe pathogen infection and reduce
mortality, antibiotics (ceﬁxime or ciproﬂoxacin) and antimalarial
treatment (compound naphthoquine phosphate tablets) were
administered empirically for the EVD patients with a high fever
before the related testing data were available. Simultaneously,
patients with pain and fever were usually treated with paraceta-
mol. Patients with excess gastric acid and vomiting were given
omeprazole and metoclopramide.
2.5. Ethics review
As a retrospective non-comparative case series study, the ethics
committee of the People’s Liberation Army 302 Hospital, which is
Figure 2. Distribution of patient age was not normally distributed: the majority of
the patients were aged 15–35-years old.
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from which the Chinese medical team originated, approved this
project. The committee waived the requirement to obtain
informed consent during this outbreak because of the special
conditions. All of the data and samples were collected for routine
medical care needs. The MoHS, NERC, and UN Mission for Ebola
Emergency Response (UNMEER) were informed of this study and
approved it.
2.6. Statistical analysis
Microsoft Excel 2007 was used to establish the database.
Quantitative continuous variables (age in years and time in days)
were tested for Gaussian distribution. If ‘yes’, the data were reported
as the arithmetic mean  standard deviation (SD); if ‘no’, the data
were reported as the median and the interquartile range (IQR). Viral
loads were transformed to the common logarithm. Outcome, sex, and
presentation of symptoms were expressed as dichotomous variables.
Pearson’s Chi-square test was used to determine the association
between mortality and the dichotomous variables: if the expected
frequency was <5, Yates’ correction was used. Kaplan–Meier methods
and log rank tests were used to determine survival curves for the
different groups of patients. The Cox proportional hazard model
was used to perform multiple comparisons for survival times. PASW
version 18.0 (SPSS Inc., Chicago, IL, USA) was used to perform the
statistical analyses. Hypothesis tests were two-tailed, with a p-value
of less than 0.05 indicating statistical signiﬁcance.
3. Results
3.1. Patient demographics
Six hundred and ninety-three probable patients who met the
deﬁnition of a suspected EVD patient were admitted to the Jui
Government Hospital from October 2014 to March 2015: 288 cases
were conﬁrmed by monitoring viral RNA (149 male (51.74%) and
139 female (48.26%)). Seventy-nine patients (27.43%) were aged
<18 years, 143 (49.65%) were between 18 and 40 years old, and
66 patients (22.92%) were aged >40 years (Figure 1). The patients’
ages were non-normally distributed: the median was 28 years (IQR
17–37.75 years) (Figure 2). Among the 288 conﬁrmed patients,
98 died and 36 recovered; the remaining 154 EVD patients were
lost to follow-up and their outcomes are unknown.
The average length of hospital stay was 2 days (IQR 2–4 days) for
the 98 who died and 14 days (IQR 9–16.75 days) for the 36 who
recovered. The fatality rate of the EVD cases was 73.13% (femalesFigure 1. Flow diagram of the diagnosis and treatment of probable and conﬁrmed
patients with Ebola virus infection. 693 probable patients were admitted to our
hospital. 288 patients were conﬁrmed to have Ebola Virus Disease (EVD) by
monitoring serum viral nucleotide acids. 134 of 288 cases had clear records: 98 of
them died from EVD (45 male and 53 female cases) and 36 cases were cured. The
remaining 154 cases were transferred to other Ebola treatment center and were lost
to follow-up. Therefore, our study mainly focused on the analysis of the detailed
data of the 134 cases with good records.79.10%, n = 53/67; males 67.16%, n = 45/67) (Figure 1). No signiﬁcant
difference was found between females and males (p = 0.119). The
average age of the patients who died was 32 years (IQR 23–43 years),
and for those who survived was 26 years (IQR 15.25–34.75 years).
The patients were divided into three groups according to age: 18,
18–40, and 40 years old. Of note, there was a signiﬁcantly lower
fatality rate for patients 18 years old (19/33, 57.58%) compared
with patients aged 18–40 years (48/62, 77.42%; p = 0.043) and 40
years (31/39, 79.49%; p = 0.044), However, there was no signiﬁcant
difference between the latter two groups (p = 0.06). The survival
curve for patients 40 years of age was drawn using the Kaplan–
Meier method and showed an identical result (Figure 4).
3.2. Patients who presented with diarrhea, fatigue, and difﬁculty
swallowing tended to die
The frequency of symptoms in the EVD patients were as
follows: fever occurred in 224 cases (77.78%), fatigue in 187 cases
(64.93%), abdominal pain in 186 cases (64.58%), headache in
181 cases (62.85%), diarrhea in 178 cases (61.81%), and vomiting in
175 cases (60.76%). Only a small proportion of patients presented
with bleeding (n = 32, 11.11%).
When the differences in clinical symptoms among the 134 EVD
cases who ﬁnished the whole follow-up check were compared, it
was found that the following symptoms were signiﬁcantly
associated with the fatality rate: diarrhea (odds ratio (OR) 2.958,
IQR 1.344–6.509; p = 0.006), fatigue (OR 2.833, IQR 1.292–6.214;
p = 0.008), and difﬁculty swallowing (OR 3.148, IQR 1.12–8.846;
p = 0.024). The frequency of other symptoms tended to be higher in
the group of patients who died than in those who survived, but there
was no signiﬁcant difference between the two groups (Figure 3).
3.3. A high viral load correlated with a high fatality rate and short
survival time
RT-PCR was used to monitor the plasma viral loads of all
conﬁrmed EVD patients and the association of plasma viral load with
survival time was further analyzed for the conﬁrmed cases. The
median log viral load value was around 6.68 (IQR 5.30–7.75) in the
Figure 3. Presentation rates of different symptoms. Patients who died tended to have most symptoms more frequently, except skin rash, coma and pain the behind eyes than
those who survived. The differences in the rates of diarrhea, fatigue and difﬁcult swallowing were signiﬁcant.
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1 000 000 Ebola virus copies per milliliter in plasma, whereas
116 cases (40.28%) had 1 000 000 virus copies per milliliter plasma.
Of note, a higher viral load was negatively correlated with survival
times in all conﬁrmed EVD patients (Figure 5). In 134 EVD patients
with a known outcome, higher viral load was positively associated
with mortality (OR 3.095, 95% conﬁdence interval (CI) 1.4–6.842).
3.4. Multivariate analysis showed that patients who presented with a
high viral load, older age, and with diarrhea had shorter survival times
To investigate how multiple variables inﬂuenced the survival of
the EVD patients, Cox regression was used to conduct a single
factor analysis among related factors, including age, viral load,Figure 4. Survival curves according to age. Kaplan-Meier Estimate of the probability
of survival showed that older patients had shorter survival times (Log-rank
(Mantel-Cox) p = 0.009. Dash line and cross represent patients 18-years-old, long
peck line and diamond represent patients of 18–40- years-old, dot line and round
represent patients >40-years-old.presentation with diarrhea, and fatigue, respectively. The ﬁndings
showed that age, viral load, and presentation with diarrhea were
closely associated with survival time (Table 1): patients of
advanced age, those with a high viral load, and those with
diarrhea had shorter survival times than patients without these
symptoms. In particular, most incurable patients died within
4 days of admission, and the vast majority of deaths occurred
within 8 days (Figure 6).
4. Discussion
Several studies have reported the clinical presentation and
outcomes of EVD in Sierra Leone, Guiana, and Liberia. The fatality
rate of EVD has ﬂuctuated widely, 36.1–89%, in differentFigure 5. Survival curves according to viral load. Kaplan-Meier estimate of the
probability of survival showed that patients who presented with higher viral load
had shorter survival times (Log-rank (Mantel-Cox) p = 0.009. Solid line and
diamond represent patients had £ 1,000,000 EBOV copies per milliliter of plasma
(log of virus load £ 6), dot line and cross represent patients presented with more
than 1,000,000 EBOV copies per milliliter (log of virus load >6).
Table 1
Cox regression analysis of possible Ebola-related variables
Variable B SE Wald Sig. Exp (b) 95% CI
Age 0.012 0.006 4.419 0.036 1.012 1.001–1.024
Log of viral load 0.298 0.070 18.224 0.000 1.347 1.175–1.544
Diarrhea 0.433 0.215 4.061 0.044 1.542 1.012–2.349
B, Bate; SE, standard error; Sig, signiﬁcance; Exp (b), relative risk; CI, conﬁdence
interval.
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studies have indicated that the fatality rate is inﬂuenced by
different viral genotypes, the whole treatment level, and other
related factors.2,12 The present study reported a relatively large
number of conﬁrmed EVD patients treated in the Jui Government
Hospital from October 1, 2014 to March 20, 2015. The clinical
presentations of these patients were recorded systematically, and
they were actively treated according to their symptoms, with
antibiotic treatment provided when necessary. Therefore, the
overall data should be representative.
Since the start of this EVD outbreak in the early days of 2014,
the fatality rate has been around 70.8%.13 Of the 288 conﬁrmed
EVD patients in this study, 134 patients had a known outcome and
the case fatality rate was 73%. Thus, the ﬁndings indicate that these
EVD patients had a higher mortality. There are many explanations
for this observation. First, antiviral drugs speciﬁc to Ebola virus
infection are not available. Second, Ansumana et al. documented a
clinical experience wherein conventional intravenous ﬂuids and
empirical treatment using antibiotics or/and antimalarial drugs
could efﬁciently reduce the mortality rate to 23.4%,14 suggesting
that supportive treatment for EVD patients as early as possible,
including sufﬁcient rehydration and electrolyte balance, plays a
critical role in reducing patient mortality. However, a shortage of
medical equipment for handling high-risk blood samples made it
difﬁcult to identify the severe cases and give them supportive
treatment early enough to prevent dehydration and electrolyte
imbalance, including hypokalemia,15 which is frequent in EVD
cases. Third, during the early days of Ebola virus infection, medical
staff were presented with non-speciﬁc symptoms in EVD patients,
and a higher infection rate occurred among the medical staff. In
addition, intravenous ﬂuids and blood sampling may lead to needle
stick injuries, which increases the risk of Ebola virus transmission
for medical staff. All these reasons led to a high rate of EVD
incidence in medical staff. For example, nearly 200 doctors andFigure 6. Survival curves at the mean of covariate showed that most of the deceased
patients died in the ﬁrst 8 days.nurses died from the Ebola virus infection in Sierra Leone between
May 23 and October 31, 2014,16 which resulted in tension and fear
of the disease not only in the general population, but also among
the medical staff. This is one of the reasons for the decrease in
number of volunteers.17 Fourth, under the hot and humid climate
in Sierra Leone, medical staff wearing PPE can only work
continuously for 1–1.5 h because of sweat-induced dehydration
and the loss of the protection role of the PPE. This working time
limitation meant that more medical staff were needed to take care
of the patients; however, no further medical staff were available in
the clinical setting, which increased the workload for existing
medical staff. From October 1, 2014 to December 31, 2015, the
study hospital was an EHC and was then designated as an ETC;
however, no difference in mortality rates was observed between
the EHC and ETC periods. Thus, comprehensive clinical therapeutic
strategies are urgently required.
EVD was once termed Ebola hemorrhagic fever because the
proportion of patients with bleeding was as high as 71–78%.18,19
However, in the present study, the incidence of bleeding was only
11.11% (32/288), which is higher than that reported by Schieffelin
et al.,20 but much lower than that in the study by Bah et al.21 On the
basis of a previous report in a large cohort study,13 the bleeding
incidence did not exceed 20.2% from the onset of this EVD
outbreak, which is signiﬁcantly different from previous outbreaks.
Although the lower incidence of bleeding may correlate with
different virus subtypes, the detailed reasons remain unclear.
Of note, there are other clinical presentations and virus-
associated markers to indicate the prognosis of patients. In this
study, more frequent fever, fatigue, abdominal pain, headache,
diarrhea, and vomiting were found among all conﬁrmed EVD
patients. There were signiﬁcant differences in fatigue, diarrhea,
and difﬁculty swallowing between the 98 patients who died and
the 36 who recovered. Non-signiﬁcantly higher incidences of other
symptoms were also found in those who died than in those who
recovered. A previous study by this group found age, viral load, and
the presence of confusion to be related with survival time and
mortality;22 as the size of this cohort in the early stage of the
outbreak was small, further studies were urgently needed. More
cases were enrolled after the end of the outbreak and the same
results were obtained, consolidating the ﬁndings. The minor
differences between these studies and data published by
colleagues related to the signiﬁcance of symptoms may be due
to the numbers of cases included and the time period in which they
were admitted.23,24 A larger cohort is needed to determine the real
inﬂuence of certain symptoms.
Schieffelin et al.20 found that non-surviving patients exhibited a
signiﬁcantly higher incidence of weakness, dizziness, and diarrhea
compared to surviving patients. The WHO Ebola Response Team
reported that clinical presentations including diarrhea, chest pain,
cough, difﬁculty swallowing, difﬁculty breathing, conjunctivitis,
sore throat, confusion, hiccups, and coma or unconsciousness
might inﬂuence survival or death after they analyzed 4507 proba-
ble and conﬁrmed cases.13 In the present study it was found that
EVD patients had a higher incidence of diarrhea, which is closely
associated with a higher mortality. Furthermore, it was found that
the mortality of EVD patients was positively associated with
patient age in the 134 EVD patients with a known outcome.
Interestingly, the plasma viral load was closely associated with the
survival time in all 288 conﬁrmed EVD patients. Thus, the ﬁndings
of the present study, in combination with previous reports from
this study group,22–24 indicate that older patients and those with
high viral loads exhibited a higher fatality rate and shorter survival
time, which is in concordance with the ﬁndings of Schieffelin
et al.20 and Bah et al.21
There are some limitations in relation to the clinical data: (1)
the medical records of the hospitalized patients who were
J. Li et al. / International Journal of Infectious Diseases 42 (2016) 34–39 39probable or conﬁrmed cases during the period when the Jui
Government Hospital was an EHC (October 1, 2014 to December
30, 2014) were incomplete. When the probable patients were
conﬁrmed as suffering from EVD, the majority were transferred
rapidly to other ETCs. As a result, clinical follow-up data for most of
the conﬁrmed cases who were admitted to other ETCs were not
available. (2) Laboratory test data were not available for all
probable and conﬁrmed cases throughout the EHC period and
during the early days of the approved ETC because the conditions
for routine blood testing were not good enough to protect the
testing personnel from viral infection. Thus, there was a tendency
to be more conservative in not conducting laboratory tests on blood
samples and intravenous ﬂuids from the patients. (3) In addition,
during the period as an EHC, the lack of staff experienced in the
disease, communication problems between patients and the
medical staff (lack of English or lower educational level, such that
some patients did not fully understand the questions asked by
doctors), the lower proportion of intravenous rehydration, and
the lack of laboratory tests (viral loads were available for all of
the patients) further contributed to the incomplete medical records.
Thus, it was a challenge for us to protect our staff from
becoming infected when managing the EVD patients in Jui
Government Hospital. Luckily, none of the Chinese medical team
staff were infected with the virus during their clinical duties. This
could be explained as follows: ﬁrst, precise speciﬁcations and
protocols were formulated and strictly enforced during the
clinical duty of all of the medical staff to prevent virus infection.
Second, the Chinese medical team staff were from the Beijing
302 Hospital, the leading and largest hospital speciﬁc for
infectious diseases in China; staff at this hospital successfully
managed patients with severe acute respiratory syndrome (SARS)
during the SARS epidemics in 2003, those with A/H1N1 inﬂuenza
in 2009, and patients from other epidemics. Based on this
experience and expertise, we followed not only the regulations
and protocols suggested by the WHO, but also proposed a series of
other protocols to prevent Ebola virus infection during clinical
duties. In particular, we put forward some important concepts
including ‘‘Taking off PPE is more important than wearing it in
the clinic’’ and ‘‘take off the PPE in different zones, according
to the rules of order’’. More importantly, a supervisor monitored
the process in real-time using CCTV throughout the time when
medical staff were performing their clinical duties to ensure their
safety .
In conclusion, the ﬁndings of this study indicate that older EVD
patients, those with a high viral load, and those with diarrhea
symptoms tended to have a shorter survival time. These patients
should receive intensive care and be treated promptly, for example
given intravenous rehydration, and their electrolyte balance
should be maintained to effectively reduce the case fatality rate.
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